AYTU vs MET · rev $66.4M vs P/E 13, rev $38.23B
Aytu BioScience Inc (AYTU) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
Aytu BioScience Inc (AYTU) is a drug manufacturers - specialty & generic company listed on US.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported AYTU revenue for 2025-06-30 was $66.4M. Net income was -$13.6M. AYTU currently screens at market cap $24.1M.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
AYTU currently screens at market cap $24.1M. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the AYTU and MET stock pages for the full models.
Not investment advice.